Last edition
News about "Sentynl Therapeutics"
Sentynl Therapeutics Completes Acquisition of Eiger BioPharmaceuticals' Zokinvy Program
Zokinvy is the first and only treatment approved by the US Food and Drug Administration (FDA) for Hutchinson-Gilford progeria syndrome (HGPS) and processing-deficient progeroid laminopathies (PDPL).
Sentynl Therapeutics | 04/05/2024 | By Abha | 1089
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members